BROADWOOD PARTNERS LP Insider Trading $OCX OncoCyte Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BROADWOOD PARTNERS LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BROADWOOD PARTNERS LP. BROADWOOD PARTNERS LP is 10% Owner in COMARCO INC ($CMRO) and 10% Owner in STAAR SURGICAL CO ($STAA) and Director in BIOTIME INC ($BTX) and in Asterias Biotherapeutics, Inc. ($ASTY) and 10% Owner in OncoCyte Corp ($OCX).
BROADWOOD PARTNERS LP in OncoCyte Corp
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of BROADWOOD PARTNERS LP: 10% Owner
Holdings: 16,776,484 shares
Current Value: $91,431,838
Latest Transaction: Feb 09 2021
$OCX Market Capitalization: $159.33M
$OCX Previous Close: $5.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BROADWOOD PARTNERS LP in OncoCyte Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ASTY, CMRO, BTX, OCX, STAA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 4.50 | 600,000 | 2,700,000 | 16,776,484 | 16.2 M to 16.8 M (+3.71 %) |
| Jan 22 2021 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 3.42 | 1,460,280 | 4,999,999 | 16,176,484 | 14.7 M to 16.2 M (+9.92 %) |
| Apr 28 2020 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 2.27 | 1,050,000 | 2,383,500 | 14,716,204 | 13.7 M to 14.7 M (+7.68 %) |
| Jan 06 2020 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 2.16 | 623,090 | 1,343,382 | 13,666,204 | 13 M to 13.7 M (+4.78 %) |
| Jan 06 2020 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 2.16 | 768,376 | 1,656,619 | 13,043,114 | 12.3 M to 13 M (+6.26 %) |
| Nov 15 2019 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 1.70 | 1,176,471 | 2,000,001 | 12,274,738 | 11.1 M to 12.3 M (+10.60 %) |
| Sep 13 2019 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 1.66 | 2,000,000 | 3,320,000 | 11,098,267 | 9.1 M to 11.1 M (+21.98 %) |
| Jul 02 2019 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 2.00 | 1,000,000 | 2,000,000 | 9,098,267 | 8.1 M to 9.1 M (+12.35 %) |
| Feb 12 2019 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 3.75 | 533,333 | 1,999,999 | 8,098,267 | 7.6 M to 8.1 M (+7.05 %) |
| Mar 30 2018 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | P | 1.26 | 3,968,254 | 5,000,000 | 7,564,934 | 3.6 M to 7.6 M (+110.33 %) |
| Jul 25 2017 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Option Exercise | J | 3.25 | 270,000 | 877,500 | 270,000 | |
| Jul 25 2017 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Option Exercise | X | 3.25 | 540,000 | 1,755,000 | 573,461 | |
| Jul 25 2017 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | X | 3.25 | 540,000 | 1,755,000 | 3,596,680 | 3.1 M to 3.6 M (+17.67 %) |
| Feb 22 2017 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Option Exercise | J | 3.25 | 212,500 | 690,625 | 212,500 | |
| Feb 22 2017 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Option Exercise | X | 3.25 | 425,000 | 1,381,250 | 1,113,461 | |
| Feb 22 2017 | OCX | OncoCyte Corp | BROADWOOD PARTNERS, L.P. | 10% Owner | Buy | X | 3.25 | 425,000 | 1,381,250 | 3,056,680 | 2.6 M to 3.1 M (+16.15 %) |
Page: 1